Skip to main content
PYXS
NASDAQ Life Sciences

Pyxis Doubles Authorized Shares to 380M After Stockholder Vote

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Biotech Stocks · Healthcare
Sentiment info
Negative
Importance info
7
Price
$1.58
Mkt Cap
$188.98M
52W Low
$1.03
52W High
$5.55
52W Position info
53% above low
Off High info
72% below high
Rel. Volume info
0.4× avg
Market data snapshot near publication time

PYXS sits 53% above its 52-week low of $1.03 on light trading volume (0.4× avg).

Summary

Pyxis stockholders approved doubling authorized common stock to 380 million shares, and the charter amendment took effect today. No shares were issued — this only expands the pool the company can draw on for future financing.


Key Events · Financing and Capital Events · PYXS

  • Authorized Shares Doubled to 380M

    Stockholders approved raising authorized common stock from 190,000,000 to 380,000,000 shares; the Certificate of Amendment was filed in Delaware and became effective November 13, 2026.

  • Large Potential Dilution Headroom

    With 119,583,637 shares outstanding as of the October 8, 2026 record date, the new authorization permits up to roughly 260 million additional shares — about 2.2x the current count — if fully used. No shares were issued in this filing.

  • Vote Passes Overwhelmingly

    Proposal One carried 78,081,809 for, 6,706,849 against and 209,021 abstain; the adjournment proposal also passed but was unnecessary given the quorum of 84,997,679 shares.

  • Follows October Capital Raise

    The authorization comes after the $110 million October offering that extended cash runway into 1H 2028, giving the company room for future financings or warrant-related issuances.


Analysis · PYXS · Life Sciences

Pyxis now has permission to issue up to 380 million common shares, double the prior 190 million, after holders approved the increase at today's Special Meeting. No shares were sold here — this is authorization only. But the headroom is large: against 119,583,637 shares outstanding on the October 8 record date, the company could roughly triple its current share count if it used the full authorization, so the vote clears the runway for future raises or warrant settlements following the $110 million October offering. The 78.1 million votes for versus 6.7 million against shows strong holder support, which reduces the risk of a contested capital raise later.

How filings like this one have moved

In the 30 days to Nov 12, 2026, 37% of the 3595 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, PYXS was trading at $1.58 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $189M. The 52-week trading range was $1.03 to $5.55. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

PYXS - Latest Insights

PYXS
Nov 05, 2026, 7:45 AM EST
Filing Type: 10-Q
Importance Score:
8
Price at Filing: $1.65
Real-time Price: $1.55 info
Change: -$0.0981 (-6%) info
Market Cap: $188.98M info
PYXS
Nov 05, 2026, 7:39 AM EST
Filing Type: 8-K
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.55 info
Change: -$0.0981 (-6%) info
Market Cap: $188.98M info
PYXS
Nov 05, 2026, 7:00 AM EST
Source: Wiseek News
Importance Score:
7
Price at Filing: $1.65
Real-time Price: $1.55 info
Change: -$0.0981 (-6%) info
Market Cap: $188.98M info
PYXS
Oct 21, 2026, 4:27 PM EDT
Filing Type: DEF 14A
Importance Score:
7
Price at Filing: $1.79
Real-time Price: $1.55 info
Change: -$0.2381 (-13%) info
Market Cap: $188.98M info
PYXS
Oct 09, 2026, 5:08 PM EDT
Filing Type: PRE 14A
Importance Score:
7
Price at Filing: $2.03
Real-time Price: $1.55 info
Change: -$0.4781 (-24%) info
Market Cap: $188.98M info